Apures Co., Ltd. (XKON:149300)

Market Cap	1.73B -80.1%
Revenue (ttm)	517.33M -0.1%
Net Income	-3.73B
EPS	-138.55
Shares Out	45.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,843
Average Volume	168,218
Open	34.00
Previous Close	39.00
Day's Range	34.00 - 39.00
52-Week Range	17.00 - 369.00
Beta	-0.80
RSI	45.07
Earnings Date	n/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test. It also manufactures and supplies Bio Membrane under the FCM brand, which ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 149300

Financial Performance

In 2018, Apures's revenue was 528.64 million, an increase of 28.45% compared to the previous year's 411.56 million. Losses were -4.68 billion, -16.82% less than in 2017.